[Investigations into the clinical significance of beta-glucuronidase as tumour indicator during radiation therapy of patients with carcinoma of the bladder (author's transl)].
We examined the activity of beta-glucuronidase in serum and urine in two different patient groups with carcinoma of the bladder. In one group the tumour was excised totally, in the other group tumour material was left. There was no correlation to be found between extension of the tumour and enzyme activity, or between the enzyme levels in urine and serum. This seems to be due to multiple factors like postoperative restitution, cystitis and radiation effects on bladder tissue.
D005966:Glucuronidase / Q000032:analysis* / Q000097:blood / Q000652:urine; D006801:Humans; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000532:radiotherapy
D005966:Glucuronidase
Untersuchungen zur klinischen Bedeutung der beta-Glucuronidase als Tumorindikator bei Blasentumorpatienten während der Strahlenbehandlung.